Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

September 30, 2007

Conditions
Osteoarthritis With Controlled Hypertension
Interventions
DRUG

Lumiracoxib

Trial Locations (1)

07936-1080

Novartis, East Hanover

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY